Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting”

267 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 267 results

Post-approval studies (Phase 4)Study completedNCT01432015
What this trial is testing

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Who this might be right for
Ovarian CancerUterine Cancer
Gynecologic Oncology Associates 20
Post-approval studies (Phase 4)UnknownNCT05434663
What this trial is testing

Safety Study of Repeat Doses of SUSTOL in Adults

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Heron Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Post-approval studies (Phase 4)Not Yet RecruitingNCT05841849
What this trial is testing

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Who this might be right for
Breast CancerChemotherapy-induced Nausea and Vomiting
Second Affiliated Hospital, School of Medicine, Zhejiang University 1,028
Post-approval studies (Phase 4)Study completedNCT02532634
What this trial is testing

Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone

Who this might be right for
CancerTumors
Kangdong Sacred Heart Hospital 292
Large-scale testing (Phase 3)Study completedNCT00080444
What this trial is testing

Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)

Who this might be right for
Vomiting
Merck Sharp & Dohme LLC 50
Not applicableStudy completedNCT04342780
What this trial is testing

Prevalence of Delayed Chemotherapy Associated Nausea

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Antje Koller 172
Large-scale testing (Phase 3)Study completedNCT00880191
What this trial is testing

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Who this might be right for
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 430
Post-approval studies (Phase 4)Study completedNCT01659775
What this trial is testing

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Who this might be right for
Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)
LG Life Sciences 389
Not applicableUnknownNCT02369107
What this trial is testing

The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Beijing Hospital of Traditional Chinese Medicine 136
Testing effectiveness (Phase 2)Ended earlyNCT03237611
What this trial is testing

Low Dose Aprepitant for Patients Receiving Carboplatin

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Albert Einstein College of Medicine 15
Post-approval studies (Phase 4)Study completedNCT00090207
What this trial is testing

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)

Who this might be right for
NauseaVomiting
Merck Sharp & Dohme LLC 477
Large-scale testing (Phase 3)Study completedNCT00601172
What this trial is testing

IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 710
Testing effectiveness (Phase 2)Study completedNCT04508400
What this trial is testing

Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Pediatric Cancer
Sun Yat-sen University 108
Early research (Phase 1)Study completedNCT00440128
What this trial is testing

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 12
Large-scale testing (Phase 3)Study completedNCT01937156
What this trial is testing

Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Solasia Pharma K.K. 313
Testing effectiveness (Phase 2)Looking for participantsNCT07169851
What this trial is testing

Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Who this might be right for
NauseaVomitingDrug-Related Side Effects and Adverse Reactions+1 more
Eli Lilly and Company 204
Not applicableStudy completedNCT02195921
What this trial is testing

Acupuncture for Chemotherapy-Induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tianjin University of Traditional Chinese Medicine 160
Large-scale testing (Phase 3)Study completedNCT01499849
What this trial is testing

Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Tesaro, Inc. 532
Large-scale testing (Phase 3)Study completedNCT02116530
What this trial is testing

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerNausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 401
Load More Results